Telomir Pharmaceuticals, Inc. Share Price

Telomir Pharmaceuticals, Inc. Share Price

NASDAQ: TELO | Micro Cap
$0.59
+$0.02 (3.46%) Last updated on 12 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Telomir Pharmaceuticals, Inc. Stock Performance

Open
$0.65
Prev. Close
$0.57
Circuit Range
N/A
Day Range
$0.59 - $0.65
Year Range
$0.55 - $1.58
Volume
752
Average Traded
$0.62

Telomir Pharmaceuticals, Inc. Share Price Today

As of 12 November 2026, Telomir Pharmaceuticals, Inc.'s share price is $0.59. The stock opened at $0.65, compared to its previous close of $0.57. During today's trading session, Telomir Pharmaceuticals, Inc.'s share price traded between $0.59 and $0.65, with an average price of $0.62. Over the past 52 weeks, the stock has recorded a high of $1.58 and a low of $0.55. In terms of performance, Telomir Pharmaceuticals, Inc.'s share price has declined by 54.22% over the last six months and is down 55.76% on a year-on-year basis.

Telomir Pharmaceuticals, Inc. Share Price Chart

Line chart of the Telomir Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 0.59 to 0.66, ending at 0.59.
$0.59$0.65
L
Show Current Price
H

Telomir Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$18.76M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.70
Revenue (TTM)
$0.00
Return On Equity (TTM)
-1171.34%
Profit Margin
N/A
Debt to Equity
0.02
Quarterly Earnings Growth YoY
65.53%

Telomir Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.06-$0.99-$47.84-$0.71
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A51.94%-4732.32%98.52%

Telomir Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$16.53-$10.41
Net Profit MarginN/AN/A
Income ChangeN/A37.02%

About Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Telomir Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.93
$0.59
-34.51%
Oct 2026
$1.17
$0.90
-23.39%
Sep 2026
$1.18
$1.18
+0.00%
Aug 2026
$1.22
$1.18
-3.28%
Jul 2026
$1.29
$1.22
-3.94%
Jun 2026
$1.24
$1.27
-1.93%
May 2026
$1.41
$1.29
-8.16%
Apr 2026
$1.25
$1.41
+10.16%
Mar 2026
$1.20
$1.28
-3.03%
Feb 2026
$1.17
$1.32
+14.78%
Jan 2026
$1.32
$1.15
-13.53%
Dec 2025
$1.31
$1.33
-0.75%

TELO Share Price FAQs